These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11195196)

  • 1. [Sodium in clinics and complications of liver cirrhosis].
    Petrova D; Kolarski V; Todorov A
    Vutr Boles; 2000; 32(1):37-40. PubMed ID: 11195196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyponatremia in Cirrhosis: An Update.
    Alukal JJ; John S; Thuluvath PJ
    Am J Gastroenterol; 2020 Nov; 115(11):1775-1785. PubMed ID: 33156095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyponatremia--with comments on hypernatremia].
    Palm C; Reimann D; Gross P
    Ther Umsch; 2000 Jun; 57(6):400-7. PubMed ID: 10894027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia in Cirrhosis--Pathogenesis, Treatment, and Prognostic Significance.
    Sinha VK; Ko B
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):361-7. PubMed ID: 26311597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypervolemic Hyponatremia (Liver).
    Solà E; Ginès P
    Front Horm Res; 2019; 52():104-112. PubMed ID: 32097916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of vasopressin receptor antagonists in hyponatremia.
    Khanna A; Menon MC
    Curr Opin Investig Drugs; 2010 Sep; 11(9):1007-14. PubMed ID: 20730695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
    Gerbes AL; Gülberg V; Ginès P; Decaux G; Gross P; Gandjini H; Djian J;
    Gastroenterology; 2003 Apr; 124(4):933-9. PubMed ID: 12671890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hyposmolar-hyponatremic syndrome in hepatic cirrhosis. Possible role of ADH].
    Cavatorta F; Brignole M; Queirolo C
    Minerva Med; 1979 Mar; 70(12):845-52. PubMed ID: 431839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F; Blei AT; Blendis LM; Thuluvath PJ
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
    Schrier RW; Fassett RG; Ohara M; Martin PY
    Proc Assoc Am Physicians; 1998; 110(5):407-11. PubMed ID: 9756091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia in cirrhosis: pathophysiology and management.
    John S; Thuluvath PJ
    World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
    Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
    Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluid, electrolyte, and acid-base disorders in liver cirrhosis].
    Kinouchi T
    Nihon Rinsho; 1994 Jan; 52(1):124-31. PubMed ID: 8114281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyponatremia in liver cirrhosis: pathogenesis and treatment].
    Guevara M; Ginès P
    Endocrinol Nutr; 2010 May; 57 Suppl 2():15-21. PubMed ID: 21130958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS
    J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
    Fukui H
    World J Gastroenterol; 2015 Nov; 21(41):11584-96. PubMed ID: 26556988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin antagonists: role in the management of hyponatremia.
    Yeates KE; Morton AR
    Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
    Ackermann D
    Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
    Møller S; Aagaard NK; Schmidt L; Grønbaek H; Hansen JB; Bendtsen F
    Dan Med J; 2012 Jan; 59(1):C4372. PubMed ID: 22239848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
    Akriviadis EA; Ervin MG; Cominelli F; Fisher DA; Reynolds TB
    Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.